Literature DB >> 27403672

Intestinal Rotation Anomalies.

Juan Carlos Pelayo, Andrea Lo.   

Abstract

Intestinal rotation abnormality (IRA) predisposes to lethal midgut volvulus. An understanding of intestinal development illustrates the process of normal intestinal rotation and fixation. An appreciation of the clinical presentation and consequences of missed IRA will enhance clinical suspicion and timely evaluation. Selecting the appropriate imaging modality to diagnose IRA requires an understanding of the benefits and limitations of each. The Ladd's procedure continues to be the appropriate surgical treatment for IRA with or without volvulus. Laparoscopy has emerged as an option for the diagnosis and treatment of IRA. Populations in which IRA is always associated, but a Ladd's procedure rarely required, include patients with congenital diaphragmatic hernia and abdominal wall defects. Prevalence of IRA is higher in children with congenital heart disease and heterotaxy syndrome; asymptomatic patients require multidisciplinary consideration of the risks and benefits of screening for IRA, whether a Ladd's procedure is required, and the timing thereof. [Pediatr Ann. 2016;45(7):e247-e250.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27403672     DOI: 10.3928/00904481-20160602-01

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  2 in total

1.  Midgut Laterality Is Driven by Hyaluronan on the Right.

Authors:  Aravind Sivakumar; Aparna Mahadevan; Mark E Lauer; Ricky J Narvaez; Siddesh Ramesh; Cora M Demler; Nathan R Souchet; Vincent C Hascall; Ron J Midura; Stavros Garantziotis; David B Frank; Koji Kimata; Natasza A Kurpios
Journal:  Dev Cell       Date:  2018-08-30       Impact factor: 12.270

2.  Isolated dextrogastria with eventration of right hemidiaphragm and hiatal hernia in an adult male.

Authors:  Shahid Aziz; Simone König; Haseeb Noor; Muhammad Nadeem; Rabaab Zahra; Faisal Rasheed
Journal:  BMC Gastroenterol       Date:  2022-02-10       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.